See more : Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) Income Statement Analysis – Financial Results
Complete financial analysis of The China Fund, Inc. (CHN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The China Fund, Inc., a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- SEEEN plc (SEEN.L) Income Statement Analysis – Financial Results
- Daibiru Corporation (8806.T) Income Statement Analysis – Financial Results
- Expleo Solutions Limited (EXPLEOSOL.NS) Income Statement Analysis – Financial Results
- Richy Place 2002 Public Company Limited (RICHY.BK) Income Statement Analysis – Financial Results
- Fury Gold Mines Limited (FURY) Income Statement Analysis – Financial Results
The China Fund, Inc. (CHN)
About The China Fund, Inc.
The China Fund, Inc. is a closed ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. It invests in the public equity markets of China that includes the People's Republic of China, Hong Kong, and Taiwan. The fund invests in stocks of companies operating across diversified sectors. It employs a combination of fundamental analysis with bottom-up approach and quantitative analysis to create its portfolio. The fund seeks to benchmarks the performance of its portfolio against the MSCI Golden Dragon Index. The China Fund, Inc. was formed on April 28, 1992 and is domiciled in the United States.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.21M | 11.22M | -117.47M | 12.36M | 106.61M | 59.00M | -54.89M | 81.15M | -23.44M | 8.62M | 10.01M | 11.62M | 13.20M | 13.86M | 12.70M | 12.86M | 16.41M | 10.79M | 9.47M | 7.04M | 5.85M | 4.11M |
| Cost of Revenue | 0.00 | 0.00 | 1.62M | 2.71M | 2.19M | 2.61M | 3.66M | 3.21M | 2.90M | 3.16M | 3.23M | 3.50M | 5.17M | 6.45M | 6.22M | 5.15M | 5.87M | 5.15M | 3.74M | 2.89M | 2.54M | 2.27M |
| Gross Profit | 28.21M | 11.22M | -119.08M | 9.65M | 104.42M | 56.39M | -58.55M | 77.93M | -26.33M | 5.46M | 6.78M | 8.12M | 8.03M | 7.41M | 6.48M | 7.71M | 10.54M | 5.64M | 5.73M | 4.15M | 3.31M | 1.84M |
| Gross Profit Ratio | 100.00% | 100.00% | 101.38% | 78.07% | 97.95% | 95.58% | 106.67% | 96.04% | 112.35% | 63.31% | 67.74% | 69.88% | 60.83% | 53.46% | 51.02% | 59.95% | 64.23% | 52.27% | 60.51% | 58.95% | 56.58% | 44.77% |
| Research & Development | 0.00 | 0.00 | -18.55 | 0.14 | 4.05 | 2.78 | -1.37 | 4.52 | -0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 954.29K | 2.06M | 937.21K | 969.90K | 954.90K | 1.68M | 4.20M | 2.27M | 4.02M | 4.53M | 4.76M | 4.99M | 1.77M | 1.50M | 1.72M | 1.40M | 2.08M | 1.51M | 1.33M | 1.20M | 1.22M | 1.19M |
| Selling & Marketing | 0.00 | 157.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 109.61K | 88.84K | 86.60K | 89.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 954.29K | 2.21M | 937.21K | 969.90K | 954.90K | 1.68M | 4.20M | 2.27M | -0.25 | 4.62M | 4.85M | 5.08M | 1.77M | 1.50M | 1.72M | 1.40M | 2.08M | 1.51M | 1.33M | 1.20M | 1.22M | 1.19M |
| Other Expenses | 27.26M | 0.00 | 70.43K | 60.07K | 83.82K | 160.28K | 343.29K | 231.01K | 15.72M | 35.25K | 160.00K | 50.00K | 420.00K | -320.00K | 70.00K | 100.00K | -20.00K | 10.00K | 10.00K | 0.00 | 0.00 | 10.00K |
| Operating Expenses | 28.21M | 2.21M | 1.01M | 1.03M | 1.04M | 1.84M | 4.54M | 2.50M | 5.53M | 17.07M | 17.49M | 58.98M | 2.19M | 1.18M | 1.79M | 1.50M | 2.06M | 1.52M | 1.34M | 1.20M | 1.22M | 1.20M |
| Cost & Expenses | 28.21M | 2.21M | 1.01M | 1.03M | 1.04M | 1.84M | 4.54M | 2.50M | -26.33M | 17.07M | 17.49M | 58.98M | 7.36M | 7.63M | 8.01M | 6.65M | 7.93M | 6.67M | 5.08M | 4.09M | 3.76M | 3.47M |
| Interest Income | 60.66K | 52.26K | 15.37K | 238.00 | 24.72K | 81.68K | 15.62K | 2.24K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.34M | 64.06M | 0.00 | 0.00 | 165.67M | 251.60M | 0.00 | 474.68M | 149.97M | -9.42M | 9.09M | 123.20M | ||
| Depreciation & Amortization | 0.00 | 1.13M | 570.16K | -670.93K | -675.28K | -1.56M | -2.27M | -2.88M | -7.30M | -4.00M | -5.16M | -6.54M | -100.85M | -166.23M | 331.34M | 503.20M | -885.94M | 952.77M | 299.91M | -18.72M | 18.21M | 245.68M |
| EBITDA | 0.00 | 10.13M | -118.44M | 0.00 | 105.00M | 55.88M | -59.65M | 75.68M | -1.51M | -7.39M | 22.34M | 64.06M | -95.02M | -160.00M | 336.03M | 509.41M | -877.46M | 956.89M | 304.31M | -15.77M | 20.30M | 246.32M |
| EBITDA Ratio | 0.00% | 90.31% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | 124.71% | -144.58% | 223.16% | 551.31% | -719.85% | -1,154.40% | 2,645.91% | 3,961.20% | -5,347.11% | 8,868.30% | 3,213.41% | -224.01% | 347.01% | 5,993.19% |
| Operating Income | 0.00 | 9.00M | -118.47M | 11.33M | 105.57M | 57.15M | -59.44M | 78.64M | 7.30M | 4.00M | 5.16M | 6.54M | 5.83M | 6.23M | 4.69M | 6.21M | 8.48M | 4.12M | 4.40M | 2.95M | 2.09M | 640.00K |
| Operating Income Ratio | 0.00% | 80.26% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | -31.16% | 46.44% | 51.52% | 56.24% | 44.17% | 44.95% | 36.93% | 48.29% | 51.68% | 38.18% | 46.46% | 41.90% | 35.73% | 15.57% |
| Total Other Income/Expenses | 27.23M | 1.10M | -117.90M | 10.66M | 0.00 | 0.00 | 0.00 | 75.75M | -1.39M | -12.46M | -381.44K | 64.06M | -50.42M | -78.98M | -519.00 | 261.82M | -442.97M | 478.09M | 149.94M | -9.30M | 9.12M | 122.48M |
| Income Before Tax | 27.23M | 10.10M | -118.47M | 11.33M | 105.57M | 57.15M | -59.44M | 78.64M | 5.91M | -8.46M | 27.50M | 70.60M | -44.59M | -72.75M | 170.36M | 257.81M | -434.49M | 482.21M | 154.34M | -6.35M | 11.21M | 123.12M |
| Income Before Tax Ratio | 96.53% | 90.06% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | -25.21% | -98.14% | 274.68% | 607.55% | -337.80% | -524.89% | 1,341.42% | 2,004.74% | -2,647.71% | 4,469.05% | 1,629.78% | -90.20% | 191.62% | 2,995.62% |
| Income Tax Expense | 0.00 | 0.00 | -601.89K | 566.17K | 566.08K | 1.27M | 216.65K | 2.97M | 5.79M | -12.46M | 22.34M | 64.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 27.23M | 10.10M | -118.47M | 11.33M | 105.57M | 57.15M | -59.44M | 78.64M | 5.79M | -8.46M | 27.50M | 70.60M | -44.59M | -72.75M | 170.36M | 257.81M | -434.49M | 482.21M | 154.34M | -6.35M | 11.21M | 123.12M |
| Net Income Ratio | 96.53% | 90.06% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | -24.71% | -98.14% | 274.68% | 607.55% | -337.80% | -524.89% | 1,341.42% | 2,004.74% | -2,647.71% | 4,469.05% | 1,629.78% | -90.20% | 191.62% | 2,995.62% |
| EPS | 2.74 | 1.01 | -11.55 | 1.09 | 10.10 | 5.36 | -3.78 | 5.00 | 0.98 | -0.54 | 1.75 | 4.50 | -2.76 | -3.19 | 7.48 | 11.32 | -23.94 | 33.07 | 10.64 | -0.44 | 1.11 | 12.23 |
| EPS Diluted | 2.74 | 1.01 | -11.55 | 1.09 | 10.10 | 5.36 | -3.78 | 5.00 | 15.41M | -0.54 | 1.75 | 4.50 | -2.76 | -3.19 | 7.48 | 11.32 | -23.94 | 33.07 | 10.64 | -0.44 | 1.11 | 12.23 |
| Weighted Avg Shares Out | 9.92M | 10.03M | 10.26M | 10.37M | 10.45M | 10.66M | 15.72M | 15.72M | 5.91M | 15.68M | 15.68M | 15.68M | 16.17M | 22.78M | 22.78M | 22.78M | 18.15M | 14.58M | 14.50M | 14.39M | 10.08M | 10.07M |
| Weighted Avg Shares Out (Dil) | 9.92M | 10.03M | 10.26M | 10.37M | 10.45M | 10.66M | 15.72M | 15.73M | 0.38 | 15.68M | 15.68M | 15.68M | 16.17M | 22.78M | 22.78M | 22.78M | 18.15M | 14.58M | 14.50M | 14.39M | 10.08M | 10.07M |
Logistics In A Post-Pandemic World
Supply chains were disrupted long before the pandemic by U.S.-China trade tensions.
The China Fund, Inc. Records First Quarter Results
NEW YORK, March 16, 2021 /PRNewswire/ -- The China Fund, Inc. (NYSE: CHN) today announced its financial results for its first fiscal quarter ended January 31, 2021. The Fund is a closed-end management investment company with the objective of seeking...
The China Fund, Inc. Announces Date of Annual Meeting of Stockholders
BOSTON, Jan. 25, 2021 /PRNewswire/ -- The China Fund, Inc. (NYSE: CHN) (the "Fund") announced today that the Fund's annual stockholder meeting (the "Meeting") will be held Tuesday, March 9, 2021 via a virtual forum at 11:15 a.m. Eastern Standard...
Reading Between The Lines Of China's Macroeconomic Message
I was a little bit surprised that the Central Committee of the Chinese Communist Party's (CCP) communique got more attention in the U.S. last week than the speech given by the governor of China's central bank.
The Month In Closed-End Funds: October 2020
For the second consecutive month, equity CEFs on average posted negative returns, declining 0.41% on a NAV basis for October. While for the seventh month in a row, fixed income CEFs witnessed returns in the black (+0.03%).
Closed-End Funds: Semi-Annual And Annual Distribution Payers
Semi-annual and annual distribution payers can be a bit of bonus for income investors. These funds are generally niche funds, investing in specific countries.
China, U.S. Take Positive Steps In Trade Between Countries
The volume of goods and services traded between the U.S. and China during July 2020 rose over their June 2020 levels as the economic recovery from the coronavirus recession continued.
China's Rapidly Expanding Credit Affects Global Markets
We again are seeing how rapidly expanding credit in China is spilling over into the global market. In reaction to its economy being slammed by covid-19, China, like many countries, has unleashed several massive stimulus programs to start things moving.
Portfolio Insights: Why China Is Not A Trade
Timing rallies to predict short and unpredictable market behavior is mission impossible. Capturing China as an asset class is not about being opportunistic; it is not a trade.
China Sector Report Q2 2020
The reopening so far has exceeded expectations as Chinese consumers shift parts of their lives online and factories move towards greater capacity utilization.
Source: https://incomestatements.info
Category: Stock Reports